Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma: A phase III GOG study

Authors :: Jayanthi S. Lea
Katherine M. Moxley
Anders Krarup-Hansen
Martee L. Hensley
Premal H. Thaker
Helen Hatcher
David Miller
Krishnansu S. Tewari
Shashikant Lele
Danielle Enserro
Petronella B. Ottevanger
Oliver Zivanovic
David M. O'Malley
Katina Robison
Jean-Yves Blay
Cyril Fisher
Source :: Journal of Clinical Oncology. 36:5505-5505
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: 5505Background: We conducted a phase III trial to determine whether adjuvant chemotherapy with gemcitabine-docetaxel followed by doxorubicin improves survival compared to observation in women with ...

Full Text Access

Tools